PPAR<i>α</i> Agonist WY-14643 Relieves Neuropathic Pain through SIRT1-Mediated Deacetylation of NF-<i>κ</i>B

<div>Acute WY-14643 treatment temporarily alleviated NP. (a) WY-14643 improved the paw withdrawal mechanical threshold (PWMT) of CCI rats. (b) WY-14643 improved the paw withdrawal thermal latency (PWTL) of CCI rats.</div>

PPAR Research

fig1

Figure 1

Figure 1: PPAR<i>α</i> Agonist WY-14643 Relieves Neuropathic Pain through SIRT1-Mediated Deacetylation of NF-<i>κ</i>B 

PPAR Research

PPARα Agonist WY-14643 Relieves Neuropathic Pain through SIRT1-Mediated Deacetylation of NF-κB

Figure 1